Back to BlackRock, Inc. BlackRock, Inc.

RNACRNAC
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in CARTESIAN THERAPEUTICS INC

BlackRock, Inc. holds 819,239 shares of RNAC (CARTESIAN THERAPEUTICS INC), worth $8.5M as of 2026-Q2. The position was increased (+36.7% shares). RNAC represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$8.5M

Current Shares

819,239

Total Value Change

-$3.3M

Total Shares Change

+159,837

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
819,239
+36.7%
$8.5M0.0%$10.42
36
2026-Q1
Decreased
599,108
-1.7%
$3.7M0.0%$7.48
0
2025-Q4
Decreased
609,696
-6.1%
$4.4M0.0%$6.94
0
2025-Q3
Decreased
649,341
-0.7%
$6.6M0.0%$9.85
0
2025-Q2
Decreased
653,840
-2.9%
$6.8M0.0%$10.68
0
2025-Q1
Increased
673,050
+2.1%
$8.9M0.0%$14.54
28
2024-Q4
New
659,402
-
$11.8M0.0%$18.76
39

Other major holders of RNAC: FMR LLC, Squarepoint Ops LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used